Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Plos Pathogens|November 8, 2021
Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variantsQingbo Shu, Tara Kenny, Jia Fan, et al.
HRB Open Research|February 27, 2025
Development of a Health Impact Assessment Implementation Model: Enhancing Intersectoral Approaches in Tackling Health Inequalities- A Mixed Methods Study ProtocolMonica O'Mullane, Tara Kenny, Kirsty Nash, et al.
Applied Biosafety : Journal of the American Biological Safety Association|August 29, 2022
Strategies for Validation of Inactivation of Viruses with Trizol® LS and Formalin SolutionsCary Retterer, Tara Kenny, Rouzbeh Zamani, et al.
Health Promotion International|June 30, 2025
Routemap for health impact assessment implementation: scoping review using the consolidated framework for implementation researchTara Kenny, Ben Harris-Roxas, Sheena McHugh, et al.
Antiviral Research|June 25, 2017
Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitorHan Cheng, Adam Schafer, Veronica Soloveva, et al.
BMC Microbiology|May 14, 2015
Heat fixation inactivates viral and bacterial pathogens and is compatible with downstream MALDI mass spectrometry tissue imagingLisa H Cazares, Sean A Van Tongeren, Julie Costantino, et al.
Immunogenetics|May 29, 2016
Cynomolgus macaque (Macaca fascicularis) immunoglobulin heavy chain locus descriptionGuo-Yun Yu, Suzanne Mate, Karla Garcia, et al.
Ebiomedicine|February 18, 2026
Systemic inflammation, delirium and clinical progression in mild-moderate Alzheimer diseaseAdam H Dyer, Helena Dolphin, Laura Morrison, et al.
Emerging Microbes & Infections|November 18, 2015
Sphingosine kinase 2 is a chikungunya virus host factor co-localized with the viral replication complexSt Patrick Reid, Sarah R Tritsch, Krishna Kota, et al.
Clinical Proteomics|September 7, 2016
Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparationsLisa H Cazares, Michael D Ward, Ernst E Brueggemann, et al.
Pageof 3